Sartorius Stedim Biotech (SSB) said today it will integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation, a global life sciences company focused on bioprocessing technologies, ...

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...

Applied and basic research is the main focus of academic research institutes, where governments and industrial organizations prefer cost-effective ways for production and development. Investments in R ...

Recent Survey Finds Commercial-Stage Use of Disposables Continuing on Upward Trajectory Bioreactors are constantly evolving, with improvements being introduced rapidly. To assess how the industry will ...

(MENAFN- EIN Presswire) EINPresswire/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Perfusion Bioreactor With ...

TAP Biosystems has announced that it will be co-presenting a new bioprocess webinar with Irvine Scientific, a major producer of cell culture media, on Wednesday March 12th 2014 at 9 am PST / 12 noon ...

(MENAFN- GlobeNewsWire - Nasdaq) The perfusion bioreactors market is booming due to rising biopharmaceutical demand, innovations in bioreactor design, and regulatory support. Key opportunities include ...